EDGAR Filing Documents for 0001193125-23-157998

Form 8-K - Current report:

SEC Accession No. 0001193125-23-157998

Filing Date

2023-05-31

Accepted

2023-05-31 17:30:55

Documents

Period of Report

2023-05-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d515559d8k.htm iXBRL	8-K	45484
2	EX-4.1	d515559dex41.htm	EX-4.1	19733
3	EX-4.2	d515559dex42.htm	EX-4.2	60321
4	EX-4.3	d515559dex43.htm	EX-4.3	82287
5	EX-10.1	d515559dex101.htm	EX-10.1	573675
6	EX-10.2	d515559dex102.htm	EX-10.2	159858
7	EX-99.1	d515559dex991.htm	EX-99.1	8167
11	GRAPHIC	g515559dsp07.jpg	GRAPHIC	9618
	Complete submission text file	0001193125-23-157998.txt		1246003

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	lyra-20230525.xsd	EX-101.SCH	2866
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	lyra-20230525_lab.xml	EX-101.LAB	17979
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	lyra-20230525_pre.xml	EX-101.PRE	11269
13	EXTRACTED XBRL INSTANCE DOCUMENT	d515559d8k_htm.xml	XML	3342

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472

Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600

Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)